We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about the safety of Tamiflu during pregnancy, breastfeeding, and its potential impact on birth control, with guidance for Indian readers.

Influenza, commonly known as the flu, can be a serious illness, especially for pregnant individuals. Prompt treatment is often crucial, and for many, Tamiflu (oseltamivir) is a go-to medication. However, when pregnancy is involved, questions about the safety of any medication arise. This article aims to provide clear, practical information for Indian readers regarding the use of Tamiflu during pregnancy, breastfeeding, and its potential impact on birth control.
Tamiflu is an antiviral medication prescribed to treat and prevent influenza. It works by inhibiting the neuraminidase enzyme, which is essential for the influenza virus to replicate and spread within the body. While effective for the general population, its use in pregnant women requires careful consideration due to potential risks to the developing fetus.
The question of whether Tamiflu is safe to take during pregnancy is complex. Currently, there is no definitive answer based on extensive clinical studies comparing Tamiflu directly against a placebo in pregnant individuals. However, available data from studies that have included pregnant women offer some reassurance.
Several studies have observed pregnant women who took Tamiflu during any trimester of their pregnancy. These observational studies have not indicated an increased risk of congenital anomalies, commonly referred to as birth defects, in infants born to mothers who used Tamiflu. Furthermore, animal studies have not shown Tamiflu to cause adverse effects on fetuses. It is important to remember, however, that animal study results do not always perfectly predict outcomes in humans.
Despite the lack of definitive human trial data, major health organizations like the Centers for Disease Control and Prevention (CDC) in the United States recommend Tamiflu as a preferred treatment option for the flu during pregnancy. This recommendation is based on the understanding that the risks associated with untreated influenza during pregnancy often outweigh the potential risks of Tamiflu.
If you are pregnant and experience flu symptoms, it is crucial to consult your doctor immediately. They can assess your condition, discuss the benefits and risks of Tamiflu, and recommend the most appropriate course of action. Your doctor will consider your individual health status and the severity of the flu. Additionally, your doctor can advise on the importance and safety of receiving a flu vaccine during pregnancy, which is a highly effective preventive measure against influenza.
For breastfeeding mothers, the decision to use Tamiflu also requires careful consideration. Tamiflu has been detected in breast milk when taken by lactating individuals.
The safety of Tamiflu for infants who consume it through breast milk is not yet fully understood, especially for infants younger than 12 weeks. While the drug is present in breast milk, the actual amount and its potential impact on a young infant's developing system are subjects that require more research.
If you are breastfeeding and considering Tamiflu treatment, it is essential to have a detailed discussion with your doctor. They will help you weigh the benefits of treating your flu against any potential risks to your baby. Your doctor will provide guidance on whether it is advisable to continue breastfeeding during your Tamiflu treatment or if alternative feeding methods should be considered temporarily.
For sexually active individuals or couples who can conceive, understanding the potential interactions between Tamiflu and birth control methods is important.
It is currently unknown whether Tamiflu affects the efficacy of hormonal birth control methods. Therefore, if you or your partner can become pregnant, it is advisable to discuss your birth control needs with your doctor while you are taking Tamiflu. Your doctor can advise on whether additional contraceptive measures should be used to ensure effective pregnancy prevention during your treatment period.
The best approach to managing the risks of influenza during pregnancy is prevention. The most effective way to prevent the flu is through vaccination.
The influenza vaccine is recommended for all pregnant individuals during each flu season. It is safe and does not pose a risk to the pregnant person or the developing baby. Getting vaccinated can significantly reduce the risk of contracting the flu and experiencing its potentially severe complications.
It is vital to seek immediate medical attention if you experience any of the following flu symptoms during pregnancy:
These symptoms could indicate a more severe case of influenza or other complications that require urgent medical care.
While the use of Tamiflu during pregnancy and breastfeeding warrants careful consideration and consultation with a healthcare professional, the available evidence suggests that the benefits of treating influenza in pregnant individuals often outweigh the potential risks. Open communication with your doctor is key to making informed decisions about your health and the health of your baby. Prioritizing flu vaccination remains the most effective strategy for preventing influenza during pregnancy.

Chronic inflammation is the underlying driver of most major diseases — from heart disease to Alzheimer's. The right anti-inflammatory foods can meaningfully reduce systemic inflammation, and the evidence behind them is stronger than you might think.
April 13, 2026
Learn about mononucleosis (mono), its symptoms like extreme fatigue and sore throat, causes like the Epstein-Barr virus, and how to manage recovery with rest and home care. Understand diagnosis and when to seek medical help.
April 1, 2026
Explore the risks of STI transmission during hand jobs, fingering, and oral sex. Learn practical prevention tips and when to get tested to protect your sexual health.
April 1, 2026